FDA Rejects Moderna's Flu Shot Application, Amidst Scrutiny of mRNA Vaccines
The Food and Drug Administration (FDA) rejected Moderna's application for its mRNA flu vaccine, mRNA-1010, citing issues with the trial's comparator vaccine, according to a report from Ars Technica. This decision, which surprised Moderna, comes amid increasing scrutiny of mRNA vaccines and actions by the FDA under the leadership of Robert F. Kennedy Jr.
The rejection of Moderna's flu shot application is a significant development in the pharmaceutical industry. The FDA's decision, as reported by Ars Technica, raises questions about the efficacy and safety of mRNA vaccines, a technology that has gained prominence in recent years, particularly with the development of COVID-19 vaccines. The specific reasons for the rejection, beyond issues with the comparator vaccine, were not detailed in the provided sources.
Meanwhile, other news, as reported by Nature News, covered topics like environmental science and technology. Additionally, Nature News reported on the immune cells that eat waste fats from fruit flies' brains.
In other news, according to Vox, group therapy is an underrated and cheaper type of therapy. Christie Tate, in her late 20s, struggled with crushing loneliness, bulimia, and suicidal thoughts. Then, she had a conversation that changed her life. "Try group," a friend told her.
The news also highlighted devastating wildfires fueled by climate change that caused significant destruction and 23 deaths in Chile and Argentina, particularly impacting ancient forests, while also raising concerns about government budget cuts, according to Nature News.
Discussion
AI Experts & Community
Be the first to comment